Health Care & Life Sciences » Biotechnology | Response Genetics Inc.

Response Genetics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
21,277.40
22,642.70
18,736.70
19,801.40
16,720.30
Cost of Goods Sold (COGS) incl. D&A
10,461.00
11,733.70
10,415.90
10,456.10
10,839.00
Gross Income
10,816.40
10,909.00
8,320.80
9,345.30
5,881.30
SG&A Expense
15,325.60
16,590.90
15,978.00
17,291.10
18,888.90
EBIT
4,509.20
5,681.90
7,657.30
7,945.80
13,007.60
Unusual Expense
371.90
-
-
-
-
Non Operating Income/Expense
221.80
-
14.00
17.10
27.10
Interest Expense
10.60
20.70
85.80
91.80
664.70
Pretax Income
4,669.10
5,702.40
7,757.10
8,020.50
13,699.40
Income Tax
1.30
-
-
-
-
Consolidated Net Income
4,670.40
5,702.40
7,757.10
8,020.50
13,699.40
Net Income
4,670.40
5,702.40
7,757.10
8,020.50
13,699.40
Net Income After Extraordinaries
4,670.40
5,702.40
7,757.10
8,020.50
13,699.40
Net Income Available to Common
4,670.40
5,702.40
7,757.10
8,020.50
13,699.40
EPS (Basic)
0.26
0.30
0.29
0.24
0.35
Basic Shares Outstanding
17,791.60
19,124.80
26,742.30
33,481.40
38,755.50
EPS (Diluted)
0.26
0.30
0.29
0.24
0.35
Diluted Shares Outstanding
17,791.60
19,124.80
26,742.30
33,481.40
38,755.50
EBITDA
4,043.50
5,315.20
7,187.20
7,312.80
12,180.00
Non-Operating Interest Income
0.70
0.10
0.00
0.00
-

About Response Genetics

View Profile
Address
1640 Marengo Street
Los Angeles California 90033
United States
Employees -
Website http://www.responsegenetics.com
Updated 07/08/2019
Response Genetics, Inc. engages in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies.